Cargando…
Obesity and its impact on COVID-19
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has proven a challenge to healthcare systems since its first appearance in late 2019. The global spread and devastating effects of coronavirus disease 2019 (COVID-19) on patients have resulted in countless studies on risk fact...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023779/ https://www.ncbi.nlm.nih.gov/pubmed/33824998 http://dx.doi.org/10.1007/s00109-021-02072-4 |
_version_ | 1783675176389443584 |
---|---|
author | de Leeuw, Angélica J. M. Oude Luttikhuis, Maureen A. M. Wellen, Annemarijn C. Müller, Christine Calkhoven, Cornelis F. |
author_facet | de Leeuw, Angélica J. M. Oude Luttikhuis, Maureen A. M. Wellen, Annemarijn C. Müller, Christine Calkhoven, Cornelis F. |
author_sort | de Leeuw, Angélica J. M. |
collection | PubMed |
description | The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has proven a challenge to healthcare systems since its first appearance in late 2019. The global spread and devastating effects of coronavirus disease 2019 (COVID-19) on patients have resulted in countless studies on risk factors and disease progression. Overweight and obesity emerged as one of the major risk factors for developing severe COVID-19. Here we review the biology of coronavirus infections in relation to obesity. In particular, we review literature about the impact of adiposity-related systemic inflammation on the COVID-19 disease severity, involving cytokine, chemokine, leptin, and growth hormone signaling, and we discuss the involvement of hyperactivation of the renin-angiotensin-aldosterone system (RAAS). Due to the sheer number of publications on COVID-19, we cannot be completed, and therefore, we apologize for all the publications that we do not cite. |
format | Online Article Text |
id | pubmed-8023779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-80237792021-04-07 Obesity and its impact on COVID-19 de Leeuw, Angélica J. M. Oude Luttikhuis, Maureen A. M. Wellen, Annemarijn C. Müller, Christine Calkhoven, Cornelis F. J Mol Med (Berl) Review The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has proven a challenge to healthcare systems since its first appearance in late 2019. The global spread and devastating effects of coronavirus disease 2019 (COVID-19) on patients have resulted in countless studies on risk factors and disease progression. Overweight and obesity emerged as one of the major risk factors for developing severe COVID-19. Here we review the biology of coronavirus infections in relation to obesity. In particular, we review literature about the impact of adiposity-related systemic inflammation on the COVID-19 disease severity, involving cytokine, chemokine, leptin, and growth hormone signaling, and we discuss the involvement of hyperactivation of the renin-angiotensin-aldosterone system (RAAS). Due to the sheer number of publications on COVID-19, we cannot be completed, and therefore, we apologize for all the publications that we do not cite. Springer Berlin Heidelberg 2021-04-06 2021 /pmc/articles/PMC8023779/ /pubmed/33824998 http://dx.doi.org/10.1007/s00109-021-02072-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review de Leeuw, Angélica J. M. Oude Luttikhuis, Maureen A. M. Wellen, Annemarijn C. Müller, Christine Calkhoven, Cornelis F. Obesity and its impact on COVID-19 |
title | Obesity and its impact on COVID-19 |
title_full | Obesity and its impact on COVID-19 |
title_fullStr | Obesity and its impact on COVID-19 |
title_full_unstemmed | Obesity and its impact on COVID-19 |
title_short | Obesity and its impact on COVID-19 |
title_sort | obesity and its impact on covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023779/ https://www.ncbi.nlm.nih.gov/pubmed/33824998 http://dx.doi.org/10.1007/s00109-021-02072-4 |
work_keys_str_mv | AT deleeuwangelicajm obesityanditsimpactoncovid19 AT oudeluttikhuismaureenam obesityanditsimpactoncovid19 AT wellenannemarijnc obesityanditsimpactoncovid19 AT mullerchristine obesityanditsimpactoncovid19 AT calkhovencornelisf obesityanditsimpactoncovid19 |